The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...
The latest report on CTE is both enlightening and alarming. As the Boston Herald reported, a groundbreaking study from Boston University researchers found that those with CTE have a much higher chance ...
Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...
Patients with advanced chronic traumatic encephalopathy (CTE), a brain disease likely caused by repeated head injuries, were more than four times as likely to develop dementia compared to those ...
The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) should be recognized as a new cause of dementia. The research, published online ...
Forget reducing wrinkles and fighting hair loss. Chronic traumatic encephalopathy (CTE) is often observed in football players due to tackles and falls. Getty Images While it hasn’t been put to the ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
(TNS) — There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs ...
There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs that ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
Students are increasingly interested in focusing on digital technology, information technology, artificial intelligence, and cybersecurity in their career and technical education courses, according to ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results